390 related articles for article (PubMed ID: 11754522)
1. Glutamate transporter and receptor function in disorders of ammonia metabolism.
Butterworth RF
Ment Retard Dev Disabil Res Rev; 2001; 7(4):276-9. PubMed ID: 11754522
[TBL] [Abstract][Full Text] [Related]
2. Effect of ammonia on astrocytic glutamate uptake/release mechanisms.
Rose C
J Neurochem; 2006 Apr; 97 Suppl 1():11-5. PubMed ID: 16635245
[TBL] [Abstract][Full Text] [Related]
3. Clinical aspects of urea cycle dysfunction and altered brain energy metabolism on modulation of glutamate receptors and transporters in acute and chronic hyperammonemia.
Natesan V; Mani R; Arumugam R
Biomed Pharmacother; 2016 Jul; 81():192-202. PubMed ID: 27261594
[TBL] [Abstract][Full Text] [Related]
4. Prolonged exposure to ammonia increases extracellular glutamate in cultured rat astrocytes.
Ohara K; Aoyama M; Fujita M; Sobue K; Asai K
Neurosci Lett; 2009 Sep; 462(2):109-12. PubMed ID: 19576960
[TBL] [Abstract][Full Text] [Related]
5. Selective loss of binding sites for the glutamate receptor ligands [3H]kainate and (S)-[3H]5-fluorowillardiine in the brains of rats with acute liver failure.
Michalak A; Butterworth RF
Hepatology; 1997 Mar; 25(3):631-5. PubMed ID: 9049210
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxicity of ammonia and glutamate: molecular mechanisms and prevention.
Felipo V; Hermenegildo C; Montoliu C; Llansola M; Miñana MD
Neurotoxicology; 1998; 19(4-5):675-81. PubMed ID: 9745928
[TBL] [Abstract][Full Text] [Related]
7. Glutamate transporters in hyperammonemia.
Butterworth RF
Neurochem Int; 2002; 41(2-3):81-5. PubMed ID: 12020607
[TBL] [Abstract][Full Text] [Related]
8. Mild mitochondrial inhibition in vivo enhances glutamate-induced neuronal damage through calpain but not caspase activation: role of ionotropic glutamate receptors.
Del Río P; Massieu L
Exp Neurol; 2008 Jul; 212(1):179-88. PubMed ID: 18495118
[TBL] [Abstract][Full Text] [Related]
9. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury.
Yi JH; Hazell AS
Neurochem Int; 2006 Apr; 48(5):394-403. PubMed ID: 16473439
[TBL] [Abstract][Full Text] [Related]
10. Ncm-D-aspartate: a novel caged D-aspartate suitable for activation of glutamate transporters and N-methyl-D-aspartate (NMDA) receptors in brain tissue.
Huang YH; Muralidharan S; Sinha SR; Kao JP; Bergles DE
Neuropharmacology; 2005 Nov; 49(6):831-42. PubMed ID: 16169022
[TBL] [Abstract][Full Text] [Related]
11. Role of glutamine in cerebral nitrogen metabolism and ammonia neurotoxicity.
Cooper AJ
Ment Retard Dev Disabil Res Rev; 2001; 7(4):280-6. PubMed ID: 11754523
[TBL] [Abstract][Full Text] [Related]
12. Glutamine synthetase in brain: effect of ammonia.
Suárez I; Bodega G; Fernández B
Neurochem Int; 2002; 41(2-3):123-42. PubMed ID: 12020613
[TBL] [Abstract][Full Text] [Related]
13. Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis.
Hermenegildo C; Monfort P; Felipo V
Hepatology; 2000 Mar; 31(3):709-15. PubMed ID: 10706562
[TBL] [Abstract][Full Text] [Related]
14. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.
Molz S; Tharine DC; Decker H; Tasca CI
Brain Res; 2008 Sep; 1231():113-20. PubMed ID: 18655777
[TBL] [Abstract][Full Text] [Related]
15. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
Cauli O; Rodrigo R; Boix J; Piedrafita B; Agusti A; Felipo V
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G503-11. PubMed ID: 18599589
[TBL] [Abstract][Full Text] [Related]
16. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.
Hermenegildo C; Montoliu C; Llansola M; Muñoz MD; Gaztelu JM; Miñana MD; Felipo V
Eur J Neurosci; 1998 Oct; 10(10):3201-9. PubMed ID: 9786213
[TBL] [Abstract][Full Text] [Related]
17. Selective blockade of astrocytic glutamate transporter GLT-1 with dihydrokainate prevents neuronal death during ouabain treatment of astrocyte/neuron cocultures.
Kawahara K; Hosoya R; Sato H; Tanaka M; Nakajima T; Iwabuchi S
Glia; 2002 Dec; 40(3):337-49. PubMed ID: 12420313
[TBL] [Abstract][Full Text] [Related]
18. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
19. Brain purine metabolism and xanthine dehydrogenase/oxidase conversion in hyperammonemia are under control of NMDA receptors and nitric oxide.
Kaminsky Y; Kosenko E
Brain Res; 2009 Oct; 1294():193-201. PubMed ID: 19646976
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
